Publications by authors named "Fiona Garner"

Claim this Profile
I
Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm).
Robert Paine, Robert Chasse, E Scott Halstead, Jay Nfonoyim, David J Park, Fiona Garner

Mil Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Monitoring: Evidence for Reductions in Occupational Exposure and Risk.
Jackie Morton, Craig Sams, Elizabeth Leese, Fiona Garner, Shahwaiz Iqbal

Front Toxicol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma.
Ahmad A Tarhini, Ila Joshi, Fiona Garner

Immunotherapy· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER Breast Cancer Patient-derived Xenograft Models.
Teeru Bihani, Hitisha K Patel, Heike Arlt, Nianjun Tao, Hai Jiang, Fiona Garner

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models.
Fiona Garner, Maysoun Shomali, Dotty Paquin, C Richard Lyttle, Gary Hattersley

Anticancer Drugs· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis